DrugDashboards

Sodium Chloride

Sodium Chloride · SODIUM CHLORIDE 9 mg/mL · Injection · Intravenous · Fresenius Kabi USA, LLC

NDC 63323-0186-10 · 25 VIAL, SINGLE-DOSE in 1 TRAY / 10 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.0883 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 1.5% of the time — roughly 10× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0883per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.1274per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$18.84per package of 25X10MLFresenius Kabi, LLC · May 15, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1Jul 2013Sep 2026$0.0883
54 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$29.00
Reported to Texas DSHS · 2026 annual filing · Fresenius Kabi USA

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$185,757
5,919 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

1.5%chance of a new FDA shortage posting for sodium chloride (injectable) in the next 90 days

sterile injectable · 13 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)

For scale: the typical drug’s chance is about 0.1% — this one is 10× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $16.68 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA088912
TE code
AP
Approval date
Jan 10, 1985
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class I · TerminatedNov 15, 2018
    Fresenius Kabi USA, LLCLabeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex. The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex. The above listed product codes and batches being recalled have stoppers containing natural rubber latex.
  • Class I · TerminatedNov 15, 2018
    Fresenius Kabi USA, LLCLabeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex. The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex. The above listed product codes and batches being recalled have stoppers containing natural rubber latex.

Manufacturers of Sodium Chloride (Injection)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationSODIUM CHLORIDE 450 mg/100mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 450 mg/50mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationSODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 3, 2026
B. Braun Medical Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Medical Care de Mexico, S.A. de C.V.SODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 2, 2026
Fresenius Medical Care Renal Therapies Group, LLCSODIUM CHLORIDE 900 mg/100mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Liebel-Flarsheim Company LLCSODIUM CHLORIDE .9 mg/mLJul 15, 2026Sep 2, 2026
Nephron Pharmaceuticals CorporationSODIUM CHLORIDE 9 mg/mLJul 15, 2026Sep 2, 2026
Sanofi Vaccines US Inc.SODIUM CHLORIDE 4.5 mg/.5mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSODIUM CHLORIDE 9 mg/mLJul 15, 2026Aug 31, 2026
Hikma Pharmaceuticals USA Inc.SODIUM CHLORIDE 9 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sodium Chloride — NDC 63323-0186-10," retrieved September 3, 2026, https://drugdashboards.com/drug/63323018610.

Free to cite with attribution — see how the data is put together.